Constantinos Michaelidis to Cost-Benefit Analysis
This is a "connection" page, showing publications Constantinos Michaelidis has written about Cost-Benefit Analysis.
Connection Strength
1.414
-
Michaelidis CI, Kern MS, Smith KJ. Cost-Effectiveness of Decision Support Strategies in Acute Bronchitis. J Gen Intern Med. 2015 Oct; 30(10):1505-10.
Score: 0.440
-
Michaelidis CI, Zimmerman RK, Nowalk MP, Smith KJ. Cost-effectiveness of programs to eliminate disparities in elderly vaccination rates in the United States. BMC Public Health. 2014 Jul 15; 14:718.
Score: 0.405
-
Michaelidis CI, Zimmerman RK, Nowalk MP, Fine MJ, Smith KJ. Cost-effectiveness of procalcitonin-guided antibiotic therapy for outpatient management of acute respiratory tract infections in adults. J Gen Intern Med. 2014 Apr; 29(4):579-86.
Score: 0.397
-
Michaelidis CI, Zimmerman RK, Nowalk MP, Smith KJ. Cost-effectiveness of a program to eliminate disparities in pneumococcal vaccination rates in elderly minority populations: an exploratory analysis. Value Health. 2013 Mar-Apr; 16(2):311-7.
Score: 0.092
-
Michaelidis CI, Zimmerman RK, Nowalk MP, Smith KJ. Estimating the cost-effectiveness of a national program to eliminate disparities in influenza vaccination rates among elderly minority groups. Vaccine. 2011 Apr 27; 29(19):3525-30.
Score: 0.080